BIOCRYST PHARMACEUTICALS, INC revenue breakdown overview

BIOCRYST PHARMACEUTICALS, INC revenue for the last year amounted to 5.63 B MXN, the most of which — 5.63 B MXN — came from its highest performing source at the moment, Oral Small Molecule and Protein Therapeutics, the year earlier bringing 5.28 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought BIOCRYST PHARMACEUTICALS, INC 4.90 B MXN.